SEC Form 3 · accession 0002151661-26-000002
Vaxcyte, Inc. · PCVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Luis Jodar
Officer — Chief Medical Officer
Period of report
Aug 31, 2026
Accepted (ET)
Sep 9, 2026 · 5:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649094
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $47.30 | holding | — | — | — | — | May 22, 2036 | Common Stock | 23,941 | — | D |
Explanation of responses
- F1Options vest monthly over 36 months from May 22, 2026, the grant date, subject to Reporting Person's continuous service to the Company through each such date.